Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Медицинская помощь матери при установленных или предполагаемых аномалиях и повреждениях плода, и антенатальной гибели плода

Список литературы

  1. Серов В.Н. Клинические рекомендации. Акушерство и гинекология. 2014. 1024 p. .
  2. Tsakiridis I., Giouleka S., Mamopoulos A., Athanasiadis A., Dagklis T. Investigation and management of stillbirth: a descriptive review of major  guidelines. J Perinat Med. 2022; 50(6):796–813. https://dx.doi.org/10.1515/jpm-2021-0403.
  3. Flenady V., Koopmans L., Middleton P., Frøen J.F., Smith G.C., Gibbons K., et al. Major risk factors for stillbirth in high-income countries: a systematic review  and meta-analysis. Lancet. 2011; 377(9774):1331–40. https://dx.doi.org/10.1016/S0140-6736(10)62233-7.
  4. Thompson R.A., Thompson J.M.D., Wilson J., Cronin R.S., Mitchell E.A., Raynes-Greenow C.H., et al. Risk factors for late preterm and term stillbirth: A secondary analysis of an  individual participant data meta-analysis. BJOG. 2023; 130(9):1060–70. https://dx.doi.org/10.1111/1471-0528.17444.
  5. Aune D., Saugstad O.D., Henriksen T., Tonstad S. Maternal body mass index and the risk of fetal death, stillbirth, and infant  death: a systematic review and meta-analysis. JAMA. 2014; 311(15):1536–46. https://dx.doi.org/10.1001/jama.2014.2269.
  6. Bonde J.P., Jørgensen K.T., Bonzini M., Palmer K.T. Miscarriage and occupational activity: a systematic review and meta-analysis  regarding shift work, working hours, lifting, standing, and physical workload. Scand J Work Environ Health. 2013; 39(4):325–34. https://dx.doi.org/10.5271/sjweh.3337.
  7. Li J., Zhao H., Song J.-M., Zhang J., Tang Y.-L., Xin C.-M. A meta-analysis of risk of pregnancy loss and caffeine and coffee consumption  during pregnancy. Int J Gynaecol Obstet. 2015; 130(2):116–22. https://dx.doi.org/10.1016/j.ijgo.2015.03.033.
  8. Ng K.Y.B., Cherian G., Kermack A.J., Bailey S., Macklon N., Sunkara S.K., et al. Systematic review and meta-analysis of female lifestyle factors and risk of  recurrent pregnancy loss. Sci Rep. 2021; 11(1):7081. https://dx.doi.org/10.1038/s41598-021-86445-2.
  9. Rabie N., Magann E., Steelman S., Ounpraseuth S. Oligohydramnios in complicated and uncomplicated pregnancy: a systematic review  and meta-analysis. Ultrasound Obstet Gynecol. 2017; 49(4):442–9. https://dx.doi.org/10.1002/uog.15929.
  10. Geng B., Zhang K., Huang X., Chen Y. A meta-analysis of the effect of Sjögren’s syndrome on adverse pregnancy  outcomes. Clinics (Sao Paulo). 2022; 77:100140. https://dx.doi.org/10.1016/j.clinsp.2022.100140.
  11. Huri M., Di Tommaso M., Seravalli V. Amniotic Fluid Disorders: From Prenatal Management to Neonatal Outcomes. Children (Basel). 2023; 10(3)https://dx.doi.org/10.3390/children10030561.
  12. Lamont K., Scott N.W., Jones G.T., Bhattacharya S. Risk of recurrent stillbirth: systematic review and meta-analysis. BMJ. 2015; 350:h3080. https://dx.doi.org/10.1136/bmj.h3080.
  13. Под ред. Г.М. Савельевой, Г.Т. Сухих, В.Н. Серова В.Е.Р. Акушерство. Национальное руководство. 2019. 1088 p. .
  14. Артымук Н.В. , Зеленина Е.М. 10 контраверсий искусственного аборта. STATUS PRAESENS ГИНЕКОЛОГИЯ, АКУШЕРСТВО, БЕСПЛОДНЫЙ БРАК. 2013; (102–107).
  15. Д. Гроссман, К. Блэнгарт П.Б. Осложнения после хирургического и медикаментозного аборта во втором триместре беременности. Проблемы репродуктивного здоровья. 2008; 100–111:12. .
  16. Кан Н.Е., Баранов И.И., Дикке Г.Б. Т.В.Л. Медикаментозное завершение беременности в сроки от 12 до 22 недель: показания, методы и результат. Акушерство и гинекология. 2016; 4:11–5. https://dx.doi.org/10.18565/aig.2016.4.11-15.
  17. Г.Б. Дикке И.В.С. Современные методы прерывания беременности в поздние сроки. Акушерство и гинекология. 2014; 83–88:1. .
  18. О материнской смертности в Российской Федерации в 2012 году: Методическое письмо Минздравсоцразвития РФ. 2013.
  19. Филиппов О.С., Токова З.З., Гата А.С., Куземин А.А., Гудимова В.В. Аборт : особенности статистики в федеральных округах России. 2016; 18(1):92–6. .
  20. Сухих Г.Т.С.В.Н.П.В.Н. и соавт. Медикаментозное прерывание беременности. Клинические рекомендации. 2015; :39. .
  21. National Abortion Federation. Clinical Policy Guidelines (A Clinician’s Guide to Medical and Surgical Abortion). Jurnal Penelitian Pendidikan Guru Sekolah Dasar. 2013; 6(August):68. .
  22. Sharma S., Sidhu H., Kaur S. Analytical study of intrauterine fetal death cases and associated maternal  conditions. Int J Appl Basic Med Res. 2016; 6(1):11–3. https://dx.doi.org/10.4103/2229-516X.173986.
  23. Bekiou A., Gourounti K. Reduced Fetal Movements and Perinatal Mortality. Mater Sociomed. 2020; 32(3):227–34. https://dx.doi.org/10.5455/msm.2020.32.227-234.
  24. Valentin L., Marsál K. Pregnancy outcome in women perceiving decreased fetal movement. Eur J Obstet Gynecol Reprod Biol. 1987; 24(1):23–32. https://dx.doi.org/10.1016/0028-2243(87)90033-5.
  25. Dutton P.J., Warrander L.K., Roberts S.A., Bernatavicius G., Byrd L.M., Gaze D., et al. Predictors of poor perinatal outcome following maternal perception of reduced  fetal movements--a prospective cohort study. PLoS One. 2012; 7(7):e39784. https://dx.doi.org/10.1371/journal.pone.0039784.
  26. Gynaecologists R.C. of O.&. Reduced Fetal Movements (Green-top Guideline No. 57). Hentet fra https://www rcog org uk/globalassets/documents/guidelines/gtg_57 pdf. 2011; .
  27. Schmidt W., Cseh I., Hara K., Kubli F. Maternal perception of fetal movements and real-time ultrasound findings. J Perinat Med. 1984; 12(6):313–8. https://dx.doi.org/10.1515/jpme.1984.12.6.313.
  28. Mangesi L., Hofmeyr G.J., Smith V., Smyth R.M. Fetal movement counting for assessment of fetal wellbeing. Cochrane Database of Systematic Reviews. 2015; 2015(10)https://dx.doi.org/10.1002/14651858.CD004909.pub3.
  29. Carroll L., Gallagher L., Smith V. Risk factors for reduced fetal movements in pregnancy: A systematic review and  meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2019; 243:72–82. https://dx.doi.org/10.1016/j.ejogrb.2019.09.028.
  30. Hoffman C.S., Messer L.C., Mendola P., Savitz D.A., Herring A.H., Hartmann K.E. Comparison of gestational age at birth based on last menstrual period and ultrasound during the first trimester. Paediatr Perinat Epidemiol. 2008; 22(6):587–96. https://dx.doi.org/10.1111/j.1365-3016.2008.00965.x.
  31. Savitz D.A., Terry J.W., Dole N., Thorp J.M., Siega-Riz A.M., Herring A.H. Comparison of pregnancy dating by last menstrual period, ultrasound scanning, and their combination. Am J Obstet Gynecol. 2002; 187(6):1660–6. https://dx.doi.org/10.1067/mob.2002.127601.
  32. Borgatta L., Kapp N. Clinical guidelines. Labor induction abortion in the second trimester. Contraception. 2011; 84(1):4–18. https://dx.doi.org/10.1016/j.contraception.2011.02.005.
  33. Bloom N., Reenen J. Van. Guideline for Fetal Auscultation (including Electronic Fetal Monitoring. NBER Working Papers. 2022; :89. .
  34. Raj S.S., Sarmishta M., Dhanalakshmi M.G. Maternal and Fetal Outcome of Fever in Pregnancy. J Evol Med Dent Sci. 2021; 10(13):925–30. .
  35. Aoyama K., Seaward P.G., Lapinsky S.E. Fetal outcome in the critically ill pregnant woman. Crit Care. 2014; 18(3):307. https://dx.doi.org/10.1186/cc13895.
  36. Le Gouez A., Benachi A., Mercier F.J. Fever and pregnancy. Anaesth Crit Care Pain Med. 2016; 35 Suppl 1:S5–12. https://dx.doi.org/10.1016/j.accpm.2016.06.007.
  37. Gilbert G.L. 1: Infections in pregnant women. Medical journal of Australia. 2002; 176(5):229–36. .
  38. Forsgren M., Broliden K., Navér L. Congenital and Opportunistic Infections. Main viral diseases with in utero transmission of pathogen during pregnancy: epidemiology, pathological features and outcome. In: Seminars in Fetal and Neonatal Medicine. Elsevier; 2007. p. 153 .
  39. Knowles A., Stone P., Le Grice J., Parker G., Ross S., Wise M., et al. Standards of Care for Women Requesting Abortion in Aotearoa New Zealand: Report of a Standards Committee to the Abortion Supervisory Committee. 2018; .
  40. Das D., Patel N. Management of the Woman with an Intrauterine Fetal Death (IUFD). In: Quick Hits in Obstetric Anesthesia. Cham: Springer International Publishing; 2022. p. 21–4 https://dx.doi.org/10.1007/978-3-030-72487-0_4.
  41. No G.G. Late intrauterine fetal death and stillbirth. October; 2010.
  42. Jaiman S., Romero R., Gotsch F., Gowrishankar S., Mohiuddin K., Gallo D.M., et al. Fetal sepsis: a cause of stillbirth. J Matern Fetal Neonatal Med. 2022; 35(25):9966–70. https://dx.doi.org/10.1080/14767058.2022.2079404.
  43. García-Pérez L., Linertová R., Álvarez-de-la-Rosa M., Bayón J.C., Imaz-Iglesia I., Ferrer-Rodríguez J., et al. Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review. The European Journal of Health Economics. 2018; 19(7):979–91. https://dx.doi.org/10.1007/s10198-017-0946-y.
  44. Кречмар М.В. Особенности пренатального медико-генетического консультирования. Журнал акушерства и женских болезней. 2007; .
  45. Ayres-de-Campos D., Spong C.Y., Chandraharan E. FIGO consensus guidelines on intrapartum fetal monitoring: Cardiotocography. Int J Gynaecol Obstet. 2015; 131(1):13–24. https://dx.doi.org/10.1016/j.ijgo.2015.06.020.
  46. Solum T., Sjöberg N.O. Antenatal cardiotocography and intrauterine death. Acta Obstet Gynecol Scand. 1980; 59(6):481–7. https://dx.doi.org/10.3109/00016348009155436.
  47. Stampalija T., Gyte G.M., Alfirevic Z. Utero-placental Doppler ultrasound for improving pregnancy outcome. Cochrane Database of Systematic Reviews. 2010; https://dx.doi.org/10.1002/14651858.CD008363.pub2.
  48. Royal College of Obstetricians and Gynaecologists. The Care of Women Requesting Induced Abortion Evidence-based Clinical Guideline Number 7. Vol. 145. 2011.https://dx.doi.org/10.1057/978-1-349-96053-8_5127.
  49. Cassidy A., Herrick C., Norton M.E., Ursell P.C., Vargas J., Kerns J.L. How does Fetal Autopsy after Pregnancy Loss or Termination for Anomalies and  other Complications Change Recurrence Risk? AJP Rep. 2019; 9(1):e30–5. https://dx.doi.org/10.1055/s-0039-1681013.
  50. Atherton D.S., McCleskey B.C., Duncan V.E. Utility of fetal autopsy findings to estimate time of intrauterine fetal demise in maternal trauma. Human Pathology Reports. 2022; 27:300586. .
  51. Yazdani S.H., Zeinalzadeh M., Bouzari Z., Golsorkhtabar-Amiri M. Effects of vaginal versus oral misoprostol to terminate second-trimester  pregnancy. Clin Exp Obstet Gynecol. 2012; 39(4):529–31. .
  52. Maslovich M.M., Burke L.M. Intrauterine Fetal Demise. In Treasure Island (FL); 2023.
  53. Maternity and Neonatal Clinical Guideline. Queensland Clinical Guideline: Stillbirth care. 2023.
  54. Begley C.M., Gyte G.M., Devane D., McGuire W., Weeks A., Biesty L.M. Active versus expectant management for women in the third stage of labour. Cochrane Database of Systematic Reviews. 2019; 2019(2)https://dx.doi.org/10.1002/14651858.CD007412.pub5.
  55. Tanha F.D., Golgachi T., Niroomand N., Ghajarzadeh M., Nasr R. Sublingual versus vaginal misoprostol for second trimester termination: a  randomized clinical trial. Arch Gynecol Obstet. 2013; 287(1):65–9. https://dx.doi.org/10.1007/s00404-012-2508-y.
  56. Ursell W. Induction of labour following fetal death. J Obstet Gynaecol Br Commonw. 1972; 79(3):260–4. https://dx.doi.org/10.1111/j.1471-0528.1972.tb15794.x.
  57. Harrop‐Griffiths W., Cook T., Gill H., Hill D., Ingram M., Makris M., et al. Regional anaesthesia and patients with abnormalities of coagulation. Anaesthesia. 2013; 68(9):966–72. https://dx.doi.org/10.1111/anae.12359.
  58. [CG] NHS. Intrauterine Fetal Death (IUFD) and Anaesthesia. 2022.
  59. Diedrich J., Drey E. Induction of fetal demise before abortion SFP Guideline 20101, Release date January 2010. Contraception. 2010; 81(6):462–73. .
  60. Senat M. V, Fischer C., Bernard J.P., Ville Y. The use of lidocaine for fetocide in late termination of pregnancy. BJOG. 2003; 110(3):296–300. .
  61. Denny C.C., Baron M.B., Lederle L., Drey E.A., Kerns J.L. Induction of fetal demise before pregnancy termination: practices of family  planning providers. Contraception. 2015; 92(3):241–5. https://dx.doi.org/10.1016/j.contraception.2015.05.002.
  62. Tufa T.H., Prager S., Lavelanet A.F., Kim C. Drugs used to induce fetal demise prior to abortion: a systematic review. Contracept X. 2020; 2:100046. https://dx.doi.org/10.1016/j.conx.2020.100046.
  63. Lohr P.A., Hayes J.L., Gemzell-Danielsson K. Surgical versus medical methods for second trimester induced abortion. Cochrane Database Syst Rev. 2008; (1):CD006714. https://dx.doi.org/10.1002/14651858.CD006714.pub2.
  64. Al R.A., Yapca O.E. Vaginal Misoprostol Compared With Buccal Misoprostol for Termination of  Second-Trimester Pregnancy: A Randomized Controlled Trial. Obstetrics and gynecology. 2015; 126(3):593–8. https://dx.doi.org/10.1097/AOG.0000000000000946.
  65. Ashok P.W., Templeton A., Wagaarachchi P.T., Flett G.M.M. Midtrimester medical termination of pregnancy: a review of 1002 consecutive  cases. Contraception. 2004; 69(1):51–8. https://dx.doi.org/10.1016/j.contraception.2003.09.006.
  66. Chen Y.-P., Wang P.-H., Tsui K.-H. Comment on the combination of mifepristone and misoprostol for the termination of  second-trimester pregnancy. Vol. 54, Taiwanese journal of obstetrics & gynecology. China (Republic : 1949- ); 2015. p. 469–70 https://dx.doi.org/10.1016/j.tjog.2015.06.006.
  67. Wagaarachchi P.T., Ashok P.W., Narvekar N.N., Smith N.C., Templeton A. Medical management of late intrauterine death using a combination of mifepristone  and misoprostol. BJOG. 2002; 109(4):443–7. https://dx.doi.org/10.1111/j.1471-0528.2002.01238.x.
  68. World Health Organization. Technical and Policy Guidance for Health Systems. Geneva; 2012.
  69. Gemzell-Danielsson K., Lalitkumar S. Second trimester medical abortion with mifepristone-misoprostol and misoprostol  alone: a review of methods and management. Reprod Health Matters. 2008; 16(31 Suppl):162–72. https://dx.doi.org/10.1016/S0968-8080(08)31371-8.
  70. Под ред. Л.В. Адамян В.Н.С.Г.Т.С.О.С.Филиппова. Акушерство и гинекология. Vol. 471. 2014.
  71. Кан Н.Е.Т.В.Л.Б.И.И. и соавт. Безопасный аборт в I и II триместрах беременности в условиях стационара. Vol. 88. 2017.
  72. Dean G., Colarossi L., Lunde B., Jacobs A.R., Porsch L.M., Paul M.E. Safety of digoxin for fetal demise before second-trimester abortion by dilation  and evacuation. Contraception. 2012; 85(2):144–9. https://dx.doi.org/10.1016/j.contraception.2011.05.016.
  73. Morris J.L., Winikoff B., Dabash R., Weeks A., Faundes A., Gemzell-Danielsson K., et al. FIGO’s updated recommendations for misoprostol used alone in gynecology and  obstetrics. Int J Gynaecol Obstet. 2017; 138(3):363–6. https://dx.doi.org/10.1002/ijgo.12181.
  74. Kapp N., Borgatta L., Stubblefield P., Vragovic O., Moreno N. Mifepristone in second-trimester medical abortion: a randomized controlled trial. Obstetrics and gynecology. 2007; 110(6):1304–10. https://dx.doi.org/10.1097/01.AOG.0000289577.32274.a5.
  75. Kerr R.S., Kumar N., Williams M.J., Cuthbert A., Aflaifel N., Haas D.M., et al. Low-dose oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews. 2021; 2021(6)https://dx.doi.org/10.1002/14651858.CD014484.
  76. Cherouny P.H., Hoskins I.A., Johnson T.R., Niebyl J.R. Multiple pregnancy with late death of one fetus. Obstetrics and gynecology. 1989; 74(3 Pt 1):318–20. .
  77. Bryan E. Loss in higher multiple pregnancy and multifetal pregnancy reduction. Twin Res. 2002; 5(3):169–74. https://dx.doi.org/10.1375/136905202320227826.
  78. Poniedziałek-Czajkowska E., Leszczyńska-Gorzelak B., Oleszczuk J. [Complications of multiple pregnancy in the 2nd and 3rd trimesters]. Ginekol Pol. 2000; 71(11):1435–44. .
  79. Hutchison P., Sill H. Lactation suppression with bromocriptine. N Z Med J. 1981; 94(694):309–10. .
  80. Single dose cabergoline versus bromocriptine in inhibition of puerperal  lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition. BMJ. 1991; 302(6789):1367–71. https://dx.doi.org/10.1136/bmj.302.6789.1367.
  81. Inoue A., Kondoh E., Suginami K., Io S., Chigusa Y., Konishi I. Vaginal delivery after placental abruption with intrauterine fetal death: A  20-year single-center experience. J Obstet Gynaecol Res. 2017; 43(4):676–81. https://dx.doi.org/10.1111/jog.13285.
  82. Yamamoto M., Takami M., Shindo R., Kasai M., Aoki S. Expectant Management Leading to Successful Vaginal Delivery following  Intrauterine Fetal Death in a Woman with an Incarcerated Uterus. Vol. 2017, Case reports in obstetrics and gynecology. United States; 2017. p. 2635275 https://dx.doi.org/10.1155/2017/2635275.
  83. Imanaka S., Naruse K., Akasaka J., Shigemitsu A., Iwai K., Kobayashi H. Vaginal delivery after placental abruption and intrauterine fetal death,  including failed cases. Int J Gynaecol Obstet. 2014; 126(2):180–1. https://dx.doi.org/10.1016/j.ijgo.2014.03.019.
  84. World Health Organization. WHO recommendations: Intrapartum care for a positive childbirth experience. Geneva:; 2018.
  85. Egbe T.O., Nkwele F.G.M., Tchente C.N., Arlette M.M.J. Sudden Fetal Death Managed by Cesarean Delivery: Case Report and Literature Review. of. 2017; 5:2. .
  86. Кастор М.В., Волков В.Г. Особенности родоразрешения при антенатальной гибели плода. Архив акушерства и гинекологии им ВФ Снегирева. 2020; 7(3):124–30. .
  87. Pirhonen J., Erkkola R. Delivery after fetal death in women with earlier cesarean section. A review. Eur J Obstet Gynecol Reprod Biol. 2021; 260:150–3. https://dx.doi.org/10.1016/j.ejogrb.2021.03.027.
  88. Nupur H., Saumya N., Prelata M., Nayan S., Aseri S., Sangeeta S. Indication of cesarean section in intrauterine fetal demise. Sch Acad J Biosci. 2014; 2(10):724–7. .
  89. Buinoiu N.F., Stoica S.I., Mat C., Panaitescu A., Peltecu G., Gica N. Mode of Delivery in Stillbirth. Maedica (Bucur). 2017; 12(2):101–5. .
  90. Wada Y., Takahashi H., Sasabuchi Y., Usui R., Ogoyama M., Suzuki H., et al. Maternal outcomes of placental abruption with intrauterine fetal death and  delivery routes: A nationwide observational study. Acta Obstet Gynecol Scand. 2023; 102(6):708–15. https://dx.doi.org/10.1111/aogs.14569.
  91. Elton R.J., Chaudhari S. Sepsis in obstetrics. BJA Educ. 2015; 15(5):259–64. .
  92. Gold K.J., Mozurkewich E.L., Puder K.S., Treadwell M.C. Maternal complications associated with stillbirth delivery: A cross-sectional  analysis. J Obstet Gynaecol. 2016; 36(2):208–12. https://dx.doi.org/10.3109/01443615.2015.1050646.
  93. Ellis A., Chebsey C., Storey C., Bradley S., Jackson S., Flenady V., et al. Systematic review to understand and improve care after stillbirth: a review of  parents’ and healthcare professionals’ experiences. BMC Pregnancy Childbirth. 2016; 16:16. https://dx.doi.org/10.1186/s12884-016-0806-2.
  94. Fretts R.C. Etiology and prevention of stillbirth. Am J Obstet Gynecol. 2005; 193(6):1923–35. https://dx.doi.org/10.1016/j.ajog.2005.03.074.
  95. Marufu T.C., Ahankari A., Coleman T., Lewis S. Maternal smoking and the risk of still birth: systematic review and  meta-analysis. BMC Public Health. 2015; 15:239. https://dx.doi.org/10.1186/s12889-015-1552-5.
  96. Sundermann A.C., Zhao S., Young C.L., Lam L., Jones S.H., Velez Edwards D.R., et al. Alcohol Use in Pregnancy and Miscarriage: A Systematic Review and Meta-Analysis. Alcohol Clin Exp Res. 2019; 43(8):1606–16. https://dx.doi.org/10.1111/acer.14124.
  97. Addis A., Moretti M.E., Ahmed Syed F., Einarson T.R., Koren G. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol. 2001; 15(4):341–69. https://dx.doi.org/10.1016/s0890-6238(01)00136-8.
  98. Pillay P., Janaki S., Manjila C. A Comparative Study of Gravidogram and Ultrasound in Detection of IUGR. J Obstet Gynaecol India. 2012; 62(4):409–12. https://dx.doi.org/10.1007/s13224-012-0292-z.
  99. Hantoushzadeh S., Kohandel Gargari O., Shafiee A., Seighali N., Ghaemi M. Glucose metabolism tests and recurrent pregnancy loss: evidence from a systematic  review and meta-analysis. Diabetol Metab Syndr. 2023; 15(1):3. https://dx.doi.org/10.1186/s13098-022-00973-z.
  100. Ramesh S., Roston A., Zimmerman L., Patel A., Lichtenberg E.S., Chor J. Misoprostol 1 to 3 h preprocedure vs. overnight osmotic dilators prior to early  second-trimester surgical abortion. Contraception. 2015; 92(3):234–40. https://dx.doi.org/10.1016/j.contraception.2015.04.005.
  101. Judd W.J., Luban N.L., Ness P.M., Silberstein L.E., Stroup M., Widmann F.K. Prenatal and perinatal immunohematology: recommendations for serologic management  of the fetus, newborn infant, and obstetric patient. Transfusion (Paris). 1990; 30(2):175–83. https://dx.doi.org/10.1046/j.1537-2995.1990.30290162907.x.
  102. Smith G.C.S. Life-table analysis of the risk of perinatal death at term and post term in singleton pregnancies. Am J Obstet Gynecol. 2001; 184(3):489–96. https://dx.doi.org/10.1067/mob.2001.109735.
  103. Smith G.C.S. Screening and prevention of stillbirth. Best Pract Res Clin Obstet Gynaecol. 2017; 38:71–82. https://dx.doi.org/10.1016/j.bpobgyn.2016.08.002.
  104. Peters M.D.J., Lisy K., Riitano D., Jordan Z., Aromataris E. Providing meaningful care for families experiencing stillbirth: a meta-synthesis  of qualitative evidence. J Perinatol. 2016; 36(1):3–9. https://dx.doi.org/10.1038/jp.2015.97.
  105. Pastor Montero S.M., Romero Sánchez J.M., Hueso Montoro C., Lillo Crespo M., Vacas Jaén A.G., Rodríguez Tirado M.B. Experiences with perinatal loss from the health professionals’ perspective. Rev Lat Am Enfermagem. 2011; 19(6):1405–12. https://dx.doi.org/10.1590/s0104-11692011000600018.
  106. Matsubara S. Psychological burden on obstetricians caused by patients’ deaths. Vol. 97, Acta obstetricia et gynecologica Scandinavica. United States; 2018. p. 1405 https://dx.doi.org/10.1111/aogs.13411.
  107. Nuzum D., Meaney S., O’Donoghue K. The impact of stillbirth on consultant obstetrician gynaecologists: a qualitative  study. BJOG. 2014; 121(8):1020–8. https://dx.doi.org/10.1111/1471-0528.12695.
  108. Shorey S., André B., Lopez V. The experiences and needs of healthcare professionals facing perinatal death: A  scoping review. Int J Nurs Stud. 2017; 68:25–39. https://dx.doi.org/10.1016/j.ijnurstu.2016.12.007.
  109. Добряков И.В., Блох М.Е., Фаерберг Л.М. Перинатальные утраты: психологические аспекты, специфика горевания, формы психологической помощи. Журнал акушерства и женских болезней. 2015; 64(3):4–10. .
  110. Злакотина Н.А. Психологическое сопровождение перинатальных потерь. Актуальные проблемы гуманитарных и естественных наук. 2015; (8–2):142–6. .
  111. Guidelines for health care professionals supporting families experiencing a  perinatal loss. Paediatr Child Health. 2001; 6(7):469–90. .
  112. Salgado H. de O., Andreucci C.B., Gomes A.C.R., Souza J.P. The perinatal bereavement project: development and evaluation of supportive  guidelines for families experiencing stillbirth and neonatal death in Southeast Brazil-a quasi-experimental before-and-after study. Reprod Health. 2021; 18(1):5. https://dx.doi.org/10.1186/s12978-020-01040-4.
  113. Gold K.J., Dalton V.K., Schwenk T.L. Hospital care for parents after perinatal death. Obstetrics and gynecology. 2007; 109(5):1156–66. https://dx.doi.org/10.1097/01.AOG.0000259317.55726.df.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*